A study of the molecule target treatment about survivin, an apoptosis inhibitor, in the prostate and renal cancer.
A study of the molecule target treatment about survivin, an apoptosis inhibitor, in the prostate and renal cancer.
批准号:
20791101
负责人:
KOIKE Hidekazu
金额:
$1.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009
中文摘要
我们评估了survivin基因表达对前列腺癌(Pca)细胞增殖的影响,并研究了survivin基因表达水平与前列腺癌病理分级的关系。在Pca细胞中,转染siRNA后,survivin基因表达降低,细胞增殖受到抑制。在前列腺活检样本中,雄激素剥夺治疗后,前列腺癌的survivin表达水平显著高于BPH或前列腺癌,并与恶性肿瘤显著相关。接下来,我们评估了survivin基因表达对肾癌(RCC)细胞增殖的影响,并研究了survivin基因表达水平与RCC临床分期的关系。在Caki-1细胞中,转染siRNA后,Survivin基因表达降低,增殖受到抑制。在临床肾细胞癌组织中,survivin在转移期的表达水平显著升高。1,25 -二羟基维生素D3 (1,25 d)抑制前列腺癌细胞的增殖。我们检测了1,25 d对前列腺癌细胞的抗肿瘤增敏作用,这是由于survivin抑制所致。在LNCaP细胞中,1,25 d降低survivin基因表达,抑制细胞增殖。另一方面,DU145细胞的survivin基因表达和细胞增殖均未受到抑制。然而,有趣的是,在转染siRNA对抗survivin后,DU145细胞的增殖被1,25 d抑制。这些研究结果表明,survivin与前列腺癌和肾癌细胞增殖有显著关联,并在1,25 d诱导的前列腺癌细胞生长抑制中起重要作用。在前列腺癌和肾癌的治疗中,消除survivin似乎是一种潜在的治疗选择。
英文摘要
We assessed the effect of survivin gene expression on the proliferation of prostate cancer (Pca) cells, and studied the association of suvivin gene expression levels with the pathological grade of Pca. In Pca cells, decrease of survivin gene expression by transfection of siRNA was accompanied by inhibition of cell proliferation of Pca cells. In prostate biopsy samples, survivin expression level of Pca was significantly higher than that of BPH or Pca after androgen deprivation therapy, and was associated significantly with high-grade cancer.Next, we assessed the effect of survivin gene expression on the proliferation of renal cancer (RCC) cells, and studied the association of suvivin gene expression levels with the clinical stage of RCC. In Caki-1 cells, decrease of Survivin gene expression by transfection of siRNA was accompanied by inhibition of the proliferation. In clinical RCC tissues, survivin expression levels in metastatic stage were significantly higher.1a,25-dihydroxyvitamin D3 (1,25D) inhibits the proliferation of prostate cancer cells. We examined the antitumor sensitization effect due to survivin inhibition in 1,25D treatment for prostate cancer cells. In LNCaP cells, 1,25D decreased survivin gene expression and inhibited cell proliferation. On the other hand, survivin gene expression and cell proliferation in DU145 cells were not inhibited. However, interestingly, after the transfection of siRNA against survivin, DU145 cell proliferation was inhibited by 1,25D.These findings suggest that survivin has a significant association with prostate and renal cancer cell proliferation and plays an essential role in 1,25D-induced cell growth inhibition in prostate cancer. It seems that the elimination of survivin in the therapy against prostate and renal cancer is a potential therapeutic option.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Survivin is associated with cell proliferation and plays a role in 1a, 25-dihydroxyvitamin D3 induced cell growth inhibition in prostate cancer.
生存素与细胞增殖相关,并在 1a, 25-二羟基维生素 D3 诱导的前列腺癌细胞生长抑制中发挥作用。
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[Koike H, Morikawa Y, Sekine Y, Arai S, Matui H, Shibata Y, Suzuki K]
通讯作者:
Suzuki K
前立腺癌細胞における活性型ビタミンD3(1α, 25(OH)2D3)によるsurvivinの発現抑制
活性维生素 D3 (1α, 25(OH)2D3) 在前列腺癌细胞中抑制生存素表达
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[小池秀和, 関根芳岳, 森川泰如, 新井誠二, 古谷洋介, 松井博, 柴田康博, 鈴木和浩]
通讯作者:
鈴木和浩
前立腺癌細胞における活性型ビタミンD3 (1α, 25(OH)2D3)によるsurvivinの発現抑制
活性维生素 D3 (1α, 25(OH)2D3) 在前列腺癌细胞中抑制生存素表达
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
[小池秀和, 関根芳岳, 森川泰如, 新井誠二, 古谷洋介, 松井博, 柴田康博, 鈴木和浩]
通讯作者:
鈴木和浩
DOI:
10.1016/j.canep.2009.06.005
发表时间:
2009-08-01
期刊:
CANCER EPIDEMIOLOGY
影响因子:
2.6
作者:
[Okamura, Keigo, Koike, Hidekazu, Suzuki, Kazuhiro]
通讯作者:
Suzuki, Kazuhiro
DOI:
10.1016/j.urology.2007.12.064
发表时间:
2008-12-01
期刊:
UROLOGY
影响因子:
2.1
作者:
[Koike, Hidekazu, Sekine, Yoshitaka, Suzuki, Kazuhiro]
通讯作者:
Suzuki, Kazuhiro
共 6 条
Basic study of the treatment with anti-survivin and heavy ion radiotherapy for drug-resistant kidney and prostate cancer.
-
批准号:25462467
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.25万
-
财政年份:2013
-
负责人:KOIKE Hidekazu
-
依托单位:
The study of the new molecular cancer treatment targeting for apoptosis inhibitor survivin.
-
批准号:22791466
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$1.75万
-
财政年份:2010
-
负责人:KOIKE Hidekazu
-
依托单位:
海外基金